---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-26-006561"
form_type: "8-K"
ticker: null
cik: "0001404935"
company_name: "THC Therapeutics, Inc."
filed_at: "2026-10-30T21:26:43+00:00"
generated_at: "2026-10-30T21:28:05.426218+00:00"
event_type: "m_and_a"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# THC Therapeutics terminates ST Holdings share exchange deal, citing accounting difficulty

## Summary
- Share Exchange Agreement with ST Holdings Group, LLC and its subsidiaries, signed June 20, 2025, was terminated by mutual agreement on October 30, 2026.
- Company cited difficulty accounting for the transaction; the parties are still discussing a possible future acquisition of some or all ST Holdings assets.
- On July 7, 2026 the company filed a Nevada Amended and Restated Certificate of Designation creating 500,000 Series D Convertible Preferred shares.
- Each Series D share carries 10 votes, converts into common at $0.01 per share, and participates with common stock in any declared dividends.
- Filing signed by Scott Cox, Interim Chief Executive Officer, and dated October 30, 2026.

## SEC filing metadata
- accession: 0001477932-26-006561
- form_type: 8-K
- cik: 0001404935
- company_name: THC Therapeutics, Inc.
- filed_at: 2026-10-30T21:26:43+00:00
- event_type: m_and_a
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1404935/000147793226006561/0001477932-26-006561-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1404935/000147793226006561/thct_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-26-006561
- JSON: https://secwatch.observer/filing/0001477932-26-006561.json
- Plain text: https://secwatch.observer/filing/0001477932-26-006561.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.